Insulin human (rDNA origin, Lilly)
基因重组人胰岛素（礼来）
Report date: 2026/05/21 20:00:22
Base Information
Drug NameInsulin human (rDNA origin, Lilly)
Drug Alias Name +[13]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[21]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyDeraya University
Inactive CompaniesWake Forest University Health SciencesHealthpartners InstituteUniversity Of Southern California +[6]
Active Indications
Inactive Indications +[7]